Rise of Molecular Point-of-Care TestingAbstract

Point-of-care testing (POCT) technology continues to advance at a fast pace, making it easier to shrink complex testing platforms into point-of-care (POC) devices. By testing at a molecular level, the accuracy of the results far surpasses previous POCT methodologies. Molecular POCT devices allow quick, easy-to-use testing in near-patient scenarios where a rapid diagnosis can be the difference between treating one patient and treating all others who would be infected if the diagnosis were delayed.

Key Takeaways

  • Access to sensitive and rapid infectious disease assays is essential for accurate diagnosis, effective treatment, and timely infection control.
  • Innovations in molecular POCT have allowed molecular testing to expand from specialty molecular diagnostics laboratories into clinical laboratories, clinics, and at the patient’s side.
  • The rapid turnaround time (TAT) of POCT combined with superior sensitivity and specificity of molecular methodologies affords the best scenario for diagnosis and containment of contagious infectious diseases.
  • For public health emergencies, molecular POCT can be used to achieve accurate, economical diagnoses, promoting early detection and mitigation to better control an infectious disease outbreak.
leafs textures

Learn more about Orchard Molecular

Orchard’s Molecular solution includes dynamic workflow support that orchestrates the entire molecular testing process from pre-analytical through post-analytical.

leafs textures

Learn more about Orchard Point-of-Care

Orchard® Point-of-Care™ offers centralized governance of a comprehensive point-of-care testing program across patient testing locations. The solution includes support for specimen collection, routing, and tracking processes, device management and integration, and a feature-rich competency module.